{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:04:46Z","timestamp":1787097886759,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.autrev.2020.102665","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T01:38:53Z","timestamp":1600306733000},"page":"102665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genetic polymorphisms in Guillain-Barr\u00e9 Syndrome: A field synopsis and systematic meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Yating","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102665_bb0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102665_bb0010","first-page":"2568","article-title":"Immunotherapy of Guillain-Barre syndrome","volume":"14","author":"Liu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl","key":"10.1016\/j.autrev.2020.102665_bb0015","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102665_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1212\/01.wnl.0000316393.54258.d1","article-title":"Economic cost of Guillain-Barre syndrome in the United States","volume":"71","author":"Frenzen","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barre syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barre syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102665_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-5728(98)00072-1","article-title":"Guillain-Barre and Fisher\u2019s syndromes subsequent to campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies","volume":"88","author":"Koga","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0036-1579633","article-title":"Polymorphisms of immunoglobulin G fc receptors in Pediatric Guillain-Barre syndrome","volume":"47","author":"Mansour","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.autrev.2020.102665_bb0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.humimm.2010.06.013","article-title":"Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barre syndrome","volume":"71","author":"Prasad","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2016.07.029","article-title":"Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barre syndrome","volume":"369","author":"Liu","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2020.102665_bb0060","first-page":"301","article-title":"Association between human leukocyte antigen-DR and demylinating Guillain-Barre syndrome","volume":"19","author":"Hasan","year":"2014","journal-title":"Neurosciences (Riyadh, Saudi Arabia)"},{"key":"10.1016\/j.autrev.2020.102665_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/acn3.744","article-title":"Toll-like receptor-4 299Gly allele is associated with Guillain-Barre syndrome in Bangladesh","volume":"6","author":"Jahan","year":"2019","journal-title":"Annals of clinical and translational neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0070","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","article-title":"IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome","volume":"54","author":"van der Pol","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2016.07.020","article-title":"No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barre syndrome in a Brazilian population","volume":"298","author":"Dourado","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.11.013","article-title":"CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barre syndrome in the Bangladeshi population","volume":"314","author":"Rahman","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","article-title":"HLA-class II alleles in Guillain-Barre syndrome and miller fisher syndrome and their association with preceding campylobacter jejuni infection","volume":"62","author":"Rees","year":"1995","journal-title":"J Neuroimmunol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2020.102665_bb0090","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/513786","article-title":"Differential distribution of HLA alleles in two forms of Guillain-Barre syndrome","volume":"176","author":"Monos","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102665_bb0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","article-title":"Genetic contribution of the tumor necrosis factor region in Guillain-Barre syndrome","volume":"44","author":"Ma","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2020.102665_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.51.2.379","article-title":"HLA and T-cell receptor gene polymorphisms in Guillain-Barre syndrome","volume":"51","author":"Ma","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0105","first-page":"429","article-title":"HLA alleles in patients with Guillain-Barre syndrome","volume":"113","author":"Li","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2020.102665_bb0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.55.5.705","article-title":"IgG fc-receptor polymorphisms in Guillain-Barre syndrome","volume":"55","author":"Vedeler","year":"2000","journal-title":"Neurology"},{"issue":"2003","key":"10.1016\/j.autrev.2020.102665_bb0115","first-page":"3074","volume":"170","author":"Magira","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2020.102665_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","article-title":"Interleukin-10 promoter polymorphisms in patients with Guillain-Barre syndrome","volume":"139","author":"Myhr","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10048-003-0144-1","article-title":"Immunoglobulin KM genes in Guillain-Barre syndrome","volume":"4","author":"Pandey","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.autrev.2020.102665_bb0130","doi-asserted-by":"crossref","unstructured":"J. Pritchard, R.A. Hughes, J.H. Rees, H.J. Willison and J.A. Nicoll, Apolipoprotein E genotypes and clinical outcome in Guillain-Barre syndrome, Journal of neurology, neurosurgery, and psychiatry 74 (2003) 971\u20133.","DOI":"10.1136\/jnnp.74.7.971"},{"key":"10.1016\/j.autrev.2020.102665_bb0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2004.01.003","article-title":"Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barre patients","volume":"150","author":"Geleijns","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.12.001","article-title":"Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome","volume":"161","author":"Geleijns","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/01.WNL.0000148727.02732.01","article-title":"HLA class II alleles are not a general susceptibility factor in Guillain-Barre syndrome","volume":"64","author":"Geleijns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2005.01.016","article-title":"Severity of Guillain-Barre syndrome is associated with fc gamma receptor III polymorphisms","volume":"162","author":"van Sorge","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes","volume":"177","author":"Caporale","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"2006","key":"10.1016\/j.autrev.2020.102665_bb0160","first-page":"4211","article-title":"Mannose-binding lectin contributes to the severity of Guillain-Barre syndrome","volume":"177","author":"Geleijns","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2020.102665_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2007.07.008","article-title":"Genetic polymorphisms of macrophage-mediators in Guillain-Barre syndrome","volume":"190","author":"Geleijns","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","article-title":"Association of tumor necrosis factor polymorphisms with Guillain-Barre syndrome","volume":"58","author":"Zhang","year":"2007","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2020.102665_bb0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2008.08.013","article-title":"Susceptibility to Guillain-Barre syndrome is not associated with CD1A and CD1E gene polymorphisms","volume":"205","author":"Kuijf","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2009.10.018","article-title":"Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in northern Indian population","volume":"218","author":"Nyati","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0404.2009.01229.x","article-title":"Immunoglobulin IgG fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome","volume":"122","author":"Sinha","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2020.102665_bb0190","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s11033-011-0892-1","article-title":"Tumor necrosis factor alpha 308 G\/a polymorphism and Guillain-Barre syndrome risk","volume":"39","author":"Jiao","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2020.102665_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2012.03.006","article-title":"Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barre syndrome","volume":"246","author":"Sang","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0200","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.12.007","article-title":"Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barre syndrome","volume":"267","author":"Blum","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clineuro.2014.03.014","article-title":"Association of HLA-DR\/DQ polymorphisms with Guillain-Barre syndrome in Tunisian patients","volume":"121","author":"Fekih-Mrissa","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2020.102665_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2016.02.028","article-title":"Association of NOD1 and NOD2 polymorphisms with Guillain-Barre syndrome in northern Indian population","volume":"363","author":"Kharwar","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2020.102665_bb0215","first-page":"3695","article-title":"Association of TLR2 and IL-8 polymorphisms and their expression in Guillain-Barr\u00e9 syndrome","volume":"7","author":"Kharwar","year":"2016","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"10.1016\/j.autrev.2020.102665_bb0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2017.06.005","article-title":"Tumor necrosis factor-alpha -863C\/A polymorphism is associated with Guillain-Barre syndrome in Bangladesh","volume":"310","author":"Jahan","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/00207454.2016.1231186","article-title":"Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barre syndrome","volume":"127","author":"Kharwar","year":"2017","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.autrev.2020.102665_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192703","article-title":"FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barre syndrome","volume":"13","author":"Islam","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2020.102665_bb0235","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acn3.50884","article-title":"Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barre syndrome","volume":"6","author":"Hayat","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2020.102665_bb0240","first-page":"e960","article-title":"Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1","author":"Jaramillo-Valverde","year":"2019","journal-title":"Molecular genetics & genomic medicine"},{"key":"10.1016\/j.autrev.2020.102665_bb0245","first-page":"105","article-title":"FcgammaRs in health and disease","volume":"350","author":"Nimmerjahn","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0250","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fimmu.2019.00805","article-title":"IgG and Fcgamma receptors in intestinal immunity and inflammation","volume":"10","author":"Castro-Dopico","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2017.00280","article-title":"Fcgamma receptor heterogeneity in leukocyte functional responses","volume":"8","author":"Rosales","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0260","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of fc-FcgammaR interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102665_bb0265","first-page":"275","article-title":"Human FcR polymorphism and disease","volume":"382","author":"Li","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0270","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1399-0039.2003.00047.x","article-title":"Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais","volume":"61","author":"Siriboonrit","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2020.102665_bb0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1586\/14737175.2015.1065732","article-title":"Guillain-Barre syndrome","volume":"15","author":"Wakerley","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.autrev.2020.102665_bb0280","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2020.102665_bb0285","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","article-title":"Anti-ganglioside antibodies induce nodal and axonal injury via Fcgamma receptor-mediated inflammation","volume":"35","author":"He","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2020.102665_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2020.102665_bb0295","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12343","article-title":"Fcgamma receptor pathways during active and passive immunization","volume":"268","author":"Bournazos","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2020.102665_bb0300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(97)00082-8","article-title":"A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain-Barre syndrome","volume":"151","author":"Sindern","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2020.102665_bb0310","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"issue":"Pt 4","key":"10.1016\/j.autrev.2020.102665_bb0315","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","article-title":"Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor","volume":"118","author":"Redford","year":"1995","journal-title":"Brain\u202f: a journal of neurology"},{"key":"10.1016\/j.autrev.2020.102665_bb0320","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s10067-017-3774-7","article-title":"Tumor necrosis factor-alpha \u2212308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-alpha","volume":"36","author":"Jahid","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102665_bb0325","first-page":"13739","article-title":"Genetic polymorphisms of the TNF-alpha-308G\/A are associated with metabolic syndrome in asthmatic patients from Hebei province","volume":"8","author":"Yang","year":"2015","journal-title":"China, Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2020.102665_bb0330","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2006.11.027","article-title":"Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation","volume":"183","author":"Taylor","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(01)01877-8","article-title":"Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha","volume":"306","author":"Weishaupt","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2020.102665_bb0340","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0896-6273(91)90344-Y","article-title":"Down-regulation of myelin-associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth","volume":"7","author":"Schneider-Schaulies","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.autrev.2020.102665_bb0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","article-title":"Major histocompatibility complex genomics and human disease","volume":"14","author":"Trowsdale","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.autrev.2020.102665_bb0350","article-title":"Comprehensive meta-analysis reveals an association of the HLA-DRB1*1602 allele with autoimmune diseases mediated predominantly by autoantibodies","volume":"102532","author":"Chen","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102665_bb0355","doi-asserted-by":"crossref","first-page":"102349","DOI":"10.1016\/j.autrev.2019.102349","article-title":"HLA in myasthenia gravis: from superficial correlation to underlying mechanism","volume":"18","author":"Zhong","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102665_bb0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2019.03.013","article-title":"Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia","volume":"18","author":"Tkachenko","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102665_bb0365","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(03)00212-1","article-title":"CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain-Barre and fisher syndromes","volume":"141","author":"Koga","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0370","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","article-title":"Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barre syndrome","volume":"12","author":"Csurhes","year":"2005","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2020.102665_bb0375","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","article-title":"Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barre syndrome patients compared to controls","volume":"15","author":"Harness","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2020.102665_bb0380","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199504203321604","article-title":"Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia","volume":"332","author":"Thursz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102665_bb0385","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.21204","article-title":"HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri","volume":"117","author":"Beskow","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2020.102665_bb0390","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 alleles are associated with different magnitudes of dengue virus-specific CD4+ T-cell responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102665_bb0395","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2249.1998.00665.x","article-title":"A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B","volume":"113","author":"Diepolder","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102665_bb0400","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain-Barre syndrome, transverse myelitis and infectious diseases","volume":"15","author":"Rodriguez","year":"2018","journal-title":"Cell Mol Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:19Z","timestamp":1761599959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1568997220302408"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102665","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms in Guillain-Barr\u00e9 Syndrome: A field synopsis and systematic meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102665"}}